Seasonal Betacoronavirus Antibodies’ Expansion Post-BNT161b2 Vaccination Associates with Reduced SARS-CoV-2 VoC Neutralization

Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19

(2021) Adam K. Wheatley et al.   Nature Communications

Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant

(2021) Carl Graham et al.   IMMUNITY

Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses

(2021) Jennifer Hicks et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

(2021) Eric J Haas et al.   LANCET

Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival

(2021) Stefania Dispinseri et al.   Nature Communications

Five priorities for universal COVID-19 vaccination

(2021) Adrien Abecassis   LANCET

SARS-CoV-2 variants, spike mutations and immune escape

(2021) William T. Harvey et al.   NATURE REVIEWS MICROBIOLOGY

Can immune responses alone reveal which COVID-19 vaccines work best?

(2021) Jon Cohen   SCIENCE

Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?

(2021) Ivana Lazarevic et al.   Viruses-Basel

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

(2020) Alba Grifoni et al.   CELL

Healthy donor T cell responses to common cold coronaviruses and SARS-CoV-2

(2020) Bezawit A. Woldemeskel et al.   JOURNAL OF CLINICAL INVESTIGATION

Isolation, propagation, genome analysis and epidemiology of HKU1 betacoronaviruses

(2014) S. R. Dominguez et al.   JOURNAL OF GENERAL VIROLOGY

International Network for Comparison of HIV Neutralization Assays: The NeutNet Report

(2009) Eva Maria Fenyö et al.   PLoS One